He & She MD Weight Loss Reviews 2026: GLP-1 Meds From $139/mo Plus Daily App Coaching
Published: August 1, 2026 · By Charly P. · 9 min read
He & She MD sells its weight loss program on a two-part promise: “meds to lose the weight, support to keep it off.” The meds half is a familiar compounded GLP-1 lineup — semaglutide injections from $139/month, oral semaglutide from $199/month, and tirzepatide injections from $199/month. The support half is what makes it worth a closer look: a dedicated iOS/Android app with 1:1 clinician messaging, GLP-1-specific coaching, and built-in progress tracking, all bundled into the plan price rather than sold as an add-on. That combination puts He & She MD in a different bracket than the pure price-play platforms on our best weight loss treatments 2026 list — but the headline price is an introductory rate, and that detail matters more than anything else in this review.
Quick Verdict: He & She MD at a Glance
| Our Rating | Strong — Best Bundled Coaching App |
|---|---|
| Best For | Patients who want structured coaching and clinician access, not just a prescription |
| Starting Price | $139/mo (semaglutide injection, first 6 months) |
| Renewal Price | $199/mo semaglutide · $239/mo oral · $289/mo tirzepatide |
| Medications | Compounded semaglutide (injectable + oral), compounded tirzepatide |
| Support | 1:1 clinician messaging, GLP-1 coaching, progress tracking in-app |
| Shipping | Free, expedited, every order |
| Membership Fees | None — plan price only |
| Insurance Required | No |
| Medical Oversight | Licensed U.S. clinicians; CMO board-certified in obesity medicine |
| Intake Time | 2–3 minute online quiz |
| In-Person Visits | None required |
What Is He & She MD?
He & She MD is a multi-vertical telehealth clinic operating across Weight Loss, Longevity, Hormone Therapy, Performance, Hair Growth and Sexual Health. The weight loss line — branded the GLP-1 Platinum Program — is its flagship: you complete a short online visit, a licensed U.S. clinician reviews your intake, and if you qualify, medication ships to your door with free expedited delivery. There are no clinics, no waiting rooms and no insurance paperwork.
What separates He & She MD from the dozens of near-identical compounded GLP-1 storefronts is the app. Most platforms treat “support” as an email address and a PDF. He & She MD builds the program around a patient app that carries 1:1 clinician access, GLP-1-specific coaching, weekly progress tracking and habit-building content. The company's own headline figure — an average of 15–25 lbs lost in 12 weeks — is explicitly drawn from a comparison of active versus passive app users, which is a candid admission that the app is doing real work in their outcomes data.
Clinically, the program is fronted by Dr. Ozita Cooper, MD, He & She MD's Chief Medical Officer, who is dual board-certified in Obesity Medicine and Emergency Medicine. Obesity-medicine board certification is a meaningful credential in a category where many platforms disclose no named medical leadership at all.
What Makes He & She MD Stand Out
- ✓Coaching, clinician messaging and progress tracking bundled into the plan price
- ✓Three GLP-1 formats: semaglutide injection, semaglutide oral, and tirzepatide injection
- ✓Named, board-certified obesity-medicine Chief Medical Officer
- ✓Free expedited shipping on every order — no shipping upcharge at any tier
- ✓No separate membership fee layered on top of medication cost
- ✓2–3 minute intake quiz with no upfront commitment
- ✓Cash-pay model — no insurance, no prior authorizations
- ✓Same platform also covers hormones, longevity, hair and sexual health
How GLP-1 Medication Actually Works
Semaglutide and tirzepatide are GLP-1 receptor agonists (tirzepatide is a dual GIP/GLP-1 agonist). They mimic incretin hormones your gut releases after eating: they slow gastric emptying, blunt appetite signalling in the hypothalamus, and improve glycaemic control. Patients describe the effect as the disappearance of “food noise” — the constant background negotiation about the next meal — which is exactly the language He & She MD uses in its own patient testimonials.
The efficacy data behind these molecules is genuinely strong. In the SURMOUNT-1 trial published in the New England Journal of Medicine, participants on the highest tirzepatide dose lost an average of roughly 21% of body weight over 72 weeks. That is the ceiling for the molecule under trial conditions with structured lifestyle support — not a promise attached to any particular telehealth subscription.
One important caveat applies to He & She MD and every compounding-based competitor. The FDA has published specific guidance on medications containing semaglutide, noting that compounded versions are not reviewed by the agency for safety, effectiveness or quality. He & She MD discloses this itself in the fine print beneath its program pages, which is more transparency than several competitors offer — but it is still the single most important thing to understand before you enrol.
How He & She MD Works — Step by Step
The entire process runs online and takes minutes to start:
- 1.Take the Quiz (2–3 minutes)
Answer questions about your goals, weight history, medical conditions and current medications. There is no charge and no commitment at this stage.
- 2.Medical Review
A licensed U.S. clinician reviews your intake and prescribes treatment only if you are an appropriate candidate. Not everyone qualifies — the program screens out patients for whom GLP-1 therapy is unsuitable.
- 3.Choose Your Program
Select semaglutide injection, oral semaglutide, or tirzepatide injection based on your clinician's guidance, your needle tolerance and your budget.
- 4.Free Expedited Delivery
Medication ships free, discreetly, and arrives within a few days. Every order includes expedited shipping at no added cost.
- 5.Onboard Into the App
Set up 1:1 clinician messaging, GLP-1-specific coaching and weekly progress tracking. This is the part of the program that He & She MD's own outcomes data credits for the difference between results.
He & She MD Pricing — Full Cost Breakdown
This is the section to read twice. He & She MD advertises prices “to start,” and that phrasing is doing real work: every promotional rate is a six-month introductory price that renews at a higher standard rate. Here is the complete picture, intro and renewal side by side.
| Semaglutide Injection — intro | $139/mo for the first 6 months (regularly $199/mo) |
|---|---|
| Semaglutide Injection — renewal | $1,194 per 6 months = $199/mo |
| Semaglutide Oral — intro | $199/mo for the first 6 months (regularly $239/mo) |
| Semaglutide Oral — renewal | $1,434 per 6 months = $239/mo |
| Tirzepatide Injection — intro | $199/mo for the first 6 months (regularly $289/mo) |
| Tirzepatide Injection — renewal | $1,734 per 6 months = $289/mo |
| First-term savings | $360 (semaglutide) · $240 (oral) · $540 (tirzepatide) |
| Shipping | Free, expedited, every order |
| Membership Fees | None |
| App, coaching & clinician messaging | Included in plan price |
| Insurance Required | No |
Read against the wider market, the intro pricing is competitive and the renewal pricing is mid-to-upper. altRx, our top-ranked value pick, runs compounded semaglutide at $89/month and tirzepatide at $149/month with no six-month term — meaningfully cheaper on both molecules, but with nothing like He & She MD's coaching stack. At the other end, TrimRx starts at $149/month and offers Lifetime Price Protection, which locks your rate permanently — the exact opposite of an intro-then-renew structure, and the strongest counter-argument to He & She MD on price predictability alone.
The honest framing: if you stay past six months, you are paying roughly $199–$289/month for a compounded GLP-1 plus a coaching app. That is defensible if you use the app. It is poor value if you were only ever going to collect the vial. Compare the full field on our weight loss provider comparison before committing to a six-month term.
He & She MD vs. Other GLP-1 Providers
| Factor | He & She MD | Typical Competitor |
|---|---|---|
| Semaglutide starting price | $139/mo (6-mo intro) | $89–$249/mo |
| Tirzepatide starting price | $199/mo (6-mo intro) | $149–$299/mo |
| Oral GLP-1 option | Yes — oral semaglutide | Uncommon |
| Price after intro term | Rises to standard rate | Varies; some lock price for life |
| Coaching app included | Yes — 1:1 messaging + tracking | Often absent or paid add-on |
| Named medical leadership | Board-certified obesity-medicine CMO | Frequently undisclosed |
| Free shipping | Yes, expedited | Varies |
| Membership fees | None | Varies |
| Insurance required | No | No |
| Medication type | Compounded (not FDA-reviewed) | Compounded or brand-name |
One row deserves special attention. He & She MD markets “brand name access like Ozempic®, Zepbound® and Wegovy®” on the same page where its footnote states the GLP-1 Platinum Program medications are compounded and not FDA-reviewed. Those two claims describe different products. If a brand-name, FDA-approved GLP-1 is what you actually want, a platform built around it — such as Hers, which prescribes FDA-approved Wegovy rather than compounded semaglutide — removes the ambiguity entirely.
He & She MD Pros & Cons — Honest Assessment
Pros
- ✓Coaching app, 1:1 clinician messaging and progress tracking included at no extra cost
- ✓Three medication formats including a genuine oral semaglutide option
- ✓$139/mo intro price is competitive for a program with this much bundled support
- ✓Named, dual board-certified obesity-medicine Chief Medical Officer
- ✓Free expedited shipping on every order, with no shipping upcharges
- ✓No membership fee stacked on top of the medication price
- ✓Discloses its compounding status in writing rather than burying it
- ✓Fast 2–3 minute intake with no payment required to check eligibility
Cons
- ✗Headline prices are 6-month intro rates that renew 30–45% higher
- ✗Pricing is structured as six-month terms, not true month-to-month
- ✗Compounded GLP-1s are not reviewed by the FDA for safety, efficacy or quality
- ✗"Brand name access" marketing sits awkwardly beside the compounded-medication footnote
- ✗The 15–25 lbs in 12 weeks figure is self-reported retrospective data, not trial data
- ✗Renewal pricing is well above budget-leading compounded competitors
Is He & She MD Right for You?
He & She MD is a great fit if you
- ✓Have tried a bare-bones GLP-1 subscription and stalled without accountability
- ✓Want coaching and clinician messaging built in rather than sold separately
- ✓Prefer an oral semaglutide option instead of weekly injections
- ✓Value a named, board-certified obesity-medicine physician behind the program
- ✓Are committing to at least six months and want the intro savings
- ✓Want one platform that can also cover hormones, longevity or hair down the line
He & She MD may not be the best fit if you
- ✗Want the lowest possible per-month price on compounded GLP-1s
- ✗Prefer month-to-month flexibility over a six-month term
- ✗Need a brand-name, FDA-approved medication specifically
- ✗Will not use a coaching app — you would be paying for support you ignore
- ✗Want a price that is locked for life rather than an intro rate
There is one more angle worth flagging for existing patients. Because He & She MD runs multiple treatment lines on the same platform, weight loss patients frequently add its Longevity program — NAD+ delivered as an injection, a topical cream or a nasal spray, all at one flat $149/month rate. We reviewed that program separately in our He & She MD NAD+ review, and it is one of the most format-flexible NAD+ offerings on the market. If cellular energy and recovery support is on your list alongside weight loss, you can explore the He & She MD NAD+ program here.
Frequently Asked Questions About He & She MD
Recommended Providers
Our editorial team’s top picks for this category.
Safety Information
GLP-1 receptor agonists carry a well-documented side-effect profile. The most common effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and abdominal discomfort — and are typically most pronounced during dose escalation. Rarer but serious risks include pancreatitis, gallbladder disease and, on the basis of rodent studies, a boxed warning for thyroid C-cell tumours; these medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2.
He & She MD requires a completed medical intake reviewed by a licensed U.S. clinician before any prescription is issued, and not every applicant qualifies. Medications in the GLP-1 Platinum Program are compounded in USP-compliant, state-regulated pharmacies and, per He & She MD's own disclosure, are not reviewed by the FDA for safety, efficacy or quality. Discuss your full medical history and current medications with the prescribing clinician, and seek care promptly for severe or persistent abdominal pain.
Our Editorial Take
He & She MD is making a bet that most of its competitors are not: that the medication is the easy part and adherence is the hard part. Bundling 1:1 clinician messaging, GLP-1-specific coaching and progress tracking into the base price — rather than charging for it, or skipping it — is the right instinct, and the company's own active-versus-passive-user data is a rare piece of honest self-assessment in a category that mostly markets on price alone. A named, dual board-certified obesity-medicine CMO adds real weight to that.
The reservation is structural, not clinical. Every advertised price is a six-month introductory rate, and the renewal is 30–45% higher: $139 becomes $199, $199 becomes $289. That is not hidden — it is spelled out in the footnotes — but it is easy to miss, and it changes the value calculation entirely. Budget for the renewal number, not the headline. Do that, actually use the app, and He & She MD is a solid choice. Skip the app and let the plan roll over, and you are paying a premium for a vial you could get cheaper elsewhere.
Final Verdict
He & She MD is one of the better-supported GLP-1 programs available, provided you go in with your eyes open on pricing. Semaglutide from $139/month, an oral option most competitors do not offer, tirzepatide from $199/month, free expedited shipping, no membership fee, and a coaching app that is genuinely part of the product rather than marketing garnish. Weigh that against six-month terms, renewal rates of $199–$289/month, and compounded medications that the FDA has not reviewed. For the patient who wants structure and accountability alongside a prescription, it earns its place. For the patient who only wants the cheapest possible vial, it does not.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.